| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.46B | +22.8% |
| Cost of Revenue | $696.1M | +30.0% |
| Gross Profit | $1.77B | +20.2% |
| R&D Expense | $716.3M | +20.0% |
| SG&A Expense | $244.0M | +11.3% |
| Operating Income | -$137.0M | +36.6% |
| Interest Expense | $3.1M | -61.3% |
| Pre-tax Income | -$55.7M | +57.7% |
| Income Tax | $15.5M |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.08B | +121.1% |
| Accounts Receivable | $499.0M | +26.9% |
| Current Assets | $3.11B | +6.5% |
| Total Assets | $3.76B | +9.6% |
| Current Liabilities | $669.5M | +19.1% |
| Total Liabilities | $806.5M | +24.4% |
| Stockholders' Equity | $2.95B | +6.1% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $505.1M | +236.3% |
| Capital Expenditures | $5.0M | -83.2% |
| Investing Cash Flow | $538.8M | +182.0% |
| Financing Cash Flow | -$462.4M | -328.9% |
| Free Cash Flow | $500.2M | +314.6% |
| +711.8% |
| Net Income | -$71.2M | +44.9% |
| EPS (Basic) | -$0.88 | +49.1% |
| EPS (Diluted) | -$0.88 | +49.1% |